Once considered cellular junk, non-coding RNAs are emerging as key players in everything from brain development to cancer — ...

How can cells be programmed to respond to complex signals and make targeted decisions, similar to a logical circuit in a computer? Researchers have developed a new approach: an RNA-based genetic ...

The stock was down 14% premarket after BioNTech announced the departures and issued revenue guidance that fell short of Wall Street’s forecasts.

Researchers reveal how DICER precisely processes RNA using dual binding pockets, ensuring accurate gene silencing, and ...

Sarepta (SRPT) stock rises on positive Phase 1/2 siRNA trial data showing muscle delivery, biomarker activity, and safety in ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.